Stanker James H 4
4 · Processa Pharmaceuticals, Inc. · Filed Aug 9, 2022
Insider Transaction Report
Form 4
Stanker James H
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2022-08-05+7,601→ 51,712 total - Tax Payment
Common Stock
2022-08-05$3.17/sh−2,462$7,805→ 49,250 total
Footnotes (1)
- [F1]Vesting of time-based restricted shares.